Category:foam boosting, surfactant agents
US / EU / FDA / JECFA / FEMA / FLAVIS / Scholar / Patent Information:
Physical Properties:
Assay: | 95.00 to 100.00
|
Food Chemicals Codex Listed: | No |
Boiling Point: | 687.40 °C. @ 760.00 mm Hg (est)
|
Flash Point: | 413.00 °F. TCC ( 211.60 °C. ) (est)
|
logP (o/w): | 7.083 (est) |
Soluble in: |
| water, 0.0003503 mg/L @ 25 °C (est) |
Organoleptic Properties:
Odor and/or flavor descriptions from others (if found). |
Cosmetic Information:
Suppliers:
Safety Information:
Preferred SDS: View |
|
Hazards identification |
|
Classification of the substance or mixture |
GHS Classification in accordance with 29 CFR 1910 (OSHA HCS) |
None found. |
GHS Label elements, including precautionary statements |
|
Pictogram | |
|
Hazard statement(s) |
None found. |
Precautionary statement(s) |
None found. |
Oral/Parenteral Toxicity: |
intraperitoneal-dog LD50 371 mg/kg Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 10, Pg. 710, 1979.
intravenous-dog LD50 371 mg/kg CARDIAC: PULSE RATE
BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD Oyo Yakuri. Pharmacometrics. Vol. 11, Pg. 263, 1976.
oral-dog LD50 3900 mg/kg Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 10, Pg. 710, 1979.
oral-human TDLo 120 mg/kg/6W VASCULAR: BP ELEVATION NOT CHARACTERIZED IN AUTONOMIC SECTION Canadian Medical Association Journal. Vol. 117, Pg. 1155, 1977.
intraperitoneal-mouse LD50 120 mg/kg "Symposium on Carbenoxolone Sodium," Robson, J.M., and F.M. Sullivan, eds., London, Butterworth, 1968Vol. -, Pg. 6, 1968.
intravenous-mouse LD50 198 mg/kg "Symposium on Carbenoxolone Sodium," Robson, J.M., and F.M. Sullivan, eds., London, Butterworth, 1968Vol. -, Pg. 6, 1968.
oral-rabbit LD50 2000 mg/kg "Symposium on Carbenoxolone Sodium," Robson, J.M., and F.M. Sullivan, eds., London, Butterworth, 1968Vol. -, Pg. 6, 1968.
intraperitoneal-rat LD50 92 mg/kg Farmaco. Vol. 49, Pg. 281, 1994.
oral-rat LD50 2450 mg/kg SKIN AND APPENDAGES (SKIN): HAIR: OTHER
LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION
CARDIAC: PULSE RATE Oyo Yakuri. Pharmacometrics. Vol. 11, Pg. 263, 1976.
|
Dermal Toxicity: |
subcutaneous-dog LD50 1060 mg/kg BEHAVIORAL: TREMOR
BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) Oyo Yakuri. Pharmacometrics. Vol. 11, Pg. 263, 1976.
subcutaneous-rat LD50 1515 mg/kg Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 10, Pg. 710, 1979.
|
Inhalation Toxicity: |
Not determined
|
Safety in Use Information:
Category: | foam boosting, surfactant agents |
Recommendation for disodium succinoyl glycyrrhetinate usage levels up to: | | not for fragrance use.
|
|
Recommendation for disodium succinoyl glycyrrhetinate flavor usage levels up to: |
| not for flavor use.
|
Safety References:
References:
Other Information:
Potential Blenders and core components note
Potential Uses:
Occurrence (nature, food, other): note
Synonyms:
| carbenoxolone disodium | | carbenoxolone, disodium salt | | glycyrrhetinic acid hydrogen succinate, disodium salt |
Articles:
|